| Record ID | marc_loc_2016/BooksAll.2016.part30.utf8:185568050:1191 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part30.utf8:185568050:1191?format=raw |
LEADER: 01191cam a22003134a 4500
001 2003044717
003 DLC
005 20080311090611.0
008 030306s2003 nyua b 001 0 eng
010 $a 2003044717
020 $a0306477440 (acid-free paper)
035 $a(DNLM)101171117
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRC271.D54$bD533 2003
060 10 $aQU 137$bD629 2003
082 00 $a616.99/4061$221
245 00 $aDNA topoisomerases in cancer therapy :$bpresent and future /$cedited by Toshiwo Andoh.
260 $aNew York :$bKluwer Academic/Plenum Publishers,$cc2003.
300 $axii, 202 p. :$bill. (some col) ;$c24 cm.
504 $aIncludes bibliographical references and index.
650 0 $aDNA topoisomerases$xInhibitors$xTherapeutic use.
650 0 $aCancer$xChemotherapy.
650 12 $aDNA Topoisomerases$xantagonists & inhibitors.
650 22 $aDrug Delivery Systems.
650 22 $aNeoplasms$xdrug therapy.
700 1 $aAndoh, Toshiwo.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0819/2003044717-d.html
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/enhancements/fy0819/2003044717-t.html